Cargando…
Systematic screening for COVID‐19 associated invasive aspergillosis in ICU patients by culture and PCR on tracheal aspirate
BACKGROUND: A high prevalence of COVID‐19 associated pulmonary aspergillosis (CAPA) has been reported, though histopathological evidence is frequently lacking. To assess the clinical significance of Aspergillus species in respiratory samples of mechanically ventilated COVID‐19 patients, we implement...
Autores principales: | van Grootveld, Rebecca, van Paassen, Judith, de Boer, Mark G.J., Claas, Eric C.J., Kuijper, Ed J., van der Beek, Martha T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8014245/ https://www.ncbi.nlm.nih.gov/pubmed/33606324 http://dx.doi.org/10.1111/myc.13259 |
Ejemplares similares
-
Implementation of a clinical decision rule for selecting empiric treatment for invasive aspergillosis in a setting with high triazole resistance
por: van de Peppel, Robert J, et al.
Publicado: (2021) -
968. Managing Invasive Aspergillosis in the Era of Diagnostic PCR and Increasing Triazole Resistance: A Modeling Study of Different Strategies
por: Van De Peppel, Robert, et al.
Publicado: (2018) -
Tracheal Aspirate Galactomannan Testing in COVID-19-Associated Pulmonary Aspergillosis
por: Román-Montes, Carla M., et al.
Publicado: (2022) -
Effect of invasive aspergillosis on risk for different causes of death in older patients with acute myeloid leukaemia or high-risk myelodysplastic syndrome
por: van Grootveld, Rebecca, et al.
Publicado: (2023) -
Incidence, risk factors and pre-emptive screening for COVID-19 associated pulmonary aspergillosis in an era of immunomodulant therapy
por: van Grootveld, Rebecca, et al.
Publicado: (2023)